Two women, same diagnosis, different futures
Two women sit in the same waiting room. Both have polycystic ovary syndrome (PCOS — a hormone condition that affects periods, skin, and fertility).
But their bodies behave differently. One has weight gain and high blood pressure. The other is slim with irregular cycles.
A new study says their heart risks are not the same either.
PCOS affects about 1 in 10 women of childbearing age. It is common, but it is not one single disease.
Doctors use something called the Rotterdam criteria to sort PCOS into four phenotypes (subtypes): A, B, C, and D. Each mix has different features — irregular cycles, signs of high male-pattern hormones, and cysts on the ovaries.
Most women only hear "you have PCOS." They rarely hear which type.
And that may be a missed chance to understand long-term heart health.
The old way versus the new way
For years, PCOS was treated mainly as a fertility and period problem. Heart risk was mentioned but not measured closely.
But here's the twist. Research increasingly shows that PCOS raises the risk of heart disease for decades after the teen years.
This new study asked a sharper question. Do all four PCOS subtypes raise heart risk the same way? Or does the type matter?
How the subtypes differ
Think of PCOS like a recipe with three ingredients: irregular periods, high male-pattern hormones (called hyperandrogenism), and cysts seen on ultrasound.
Phenotype A has all three. Phenotype B has irregular periods plus high hormones, but no cysts. Phenotype C has high hormones and cysts, but regular periods. Phenotype D has irregular periods and cysts, but normal hormone levels.
A, B, and C all share that hormone piece. D does not. And that one difference seems to matter a lot.
Researchers in China looked at 206 women with PCOS at a single hospital. They measured weight, waist size, blood pressure, blood sugar, and cholesterol.
Then they used a Chinese heart-risk calculator called China-PAR to estimate each woman's chance of developing heart disease. They compared the four subtypes side by side.
Women with types A, B, and C had higher body mass index, larger waists, and higher blood pressure than women with type D.
In plain English, the three types that involve high male-pattern hormones carried more heart-risk warning signs. Type D — the one without extra hormones — looked more like the general population.
This does not mean type D is "safe." It means the extra metabolic weight is not as heavy.
The researchers also found that body measurements like BMI and waist size partly explain the link between PCOS type and heart risk. That is useful news — because weight and waist are things women can work on.
The surprising shift
For a long time, PCOS care focused on periods and pregnancy. The heart was a later worry.
This study flips the order for women with types A, B, and C. Their heart risk shows up early — in blood pressure and metabolism — even in their 20s and 30s.
That is a chance to act decades before a heart attack would normally appear.
The researchers argue that PCOS care should be personalized by type. A woman with phenotype A may need tighter blood pressure checks, earlier cholesterol screening, and lifestyle coaching.
A woman with phenotype D might not need the same intensive heart work-up, though regular checks still matter.
This fits a wider move in medicine toward precision care. The one-size-fits-all label is giving way to tailored plans based on biology.
If you have PCOS, ask your doctor which phenotype you have. If they have not classified it, ask why. The answer is usually in your chart — your period history, hormone tests, and ultrasound results.
Knowing your type can guide how often you check blood pressure and cholesterol. It can also shape how hard to push on weight, diet, and exercise.
None of this is about fear. It is about planning.
Limitations to keep in mind
This study included just 206 women at one hospital in China. That is a small group in a single setting.
The design was cross-sectional — a snapshot in time. It cannot prove that one phenotype causes more heart attacks later. It can only show links.
Results in Chinese women may not apply perfectly to women in other countries, where body size and risk calculators differ.
Larger studies across many countries are needed to confirm that phenotype truly shapes long-term heart outcomes. Ideally, researchers will follow women for 10 or 20 years to see who actually develops heart disease.
If those studies confirm these findings, guidelines may one day tell doctors to treat PCOS heart risk based on type — not just the diagnosis.
For now, the message is simpler. PCOS is not one disease. And knowing your type may be the most useful thing your chart can tell you.